1 September 2024

Starpharma presents at ASX Investor Series

Melbourne, Australia; Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) is presenting today to more than 200 investors at ASX Investor Series event in Sydney.

 

The ASX Investor Series is hosted by the ASX in conjunction with Finance News Network (FNN) and is designed to engage the investment community and bring together ASX-listed companies, investors and financial market participants.

The event will be filmed and broadcast across FNN and ASX's channels for wide-scale distribution, providing an opportunity to reach investors beyond the event.

“Starpharma welcomes this opportunity to present the Company’s recent achievements and to build on our strong relationships with retail and institutional investors,” said Dr Fairley.


“This is a terrific opportunity to broaden awareness and understanding of the Starpharma story and our three portfolios VivaGel®, Drug Delivery and Agrochemicals.

 

View Presentation: ASX Investor Series Presentation (external link)

 

Watch Video:  Interview with Dr Jackie Fairley (external link)

This contains certain forward-looking statements.

Important Notice

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.